Share
183 Posts.
lightbulb Created with Sketch. 86
clock Created with Sketch.
04/11/22
10:56
Share
Originally posted by tinhat:
↑
I welcome this news. The proposed options grant to JG was not appropriate given the share price performance and the dilution shareholders are suffering under the ATM scheme at this distressed share price. I voted against that resolution. The company does tend to miss the mark in explaining research results that could and have caused panic in the market. I also warned at the time that James shaving off his beard was a bad omen! I bet all holders regret not selling their shares at above $1.50, but after having traded KZA for some time to get my average buy down, I decided to hold come what may once we went into the Agile trial, as a long term speckie and not try and second guess where the share price is going because it all comes down to trial results of which we have can have no foresight into. I've been accumulating. This is a highly speculative biotech punt.
Expand
With the withdrawal of the resolution, we will never get to know the widespread anger directed towards the Board and the CEO. I voted a resounding "No" to this resolution.